Concepedia

Shuai Dong

SD

Statistics

Publications

15

Citations

670

H-Index

13

Active since

2009

Affiliations

The Ohio State University(Current)

Dana-Farber Cancer Institute

Shandong First Medical University

Shandong Tumor Hospital

The First Affiliated Hospital, Sun Yat-sen University

Shuai Dong is an author at The Ohio State University specializing in oncology, life sciences, and medicine.

ORCID

Publications per year

2009–2024

15

Publications

15

Hypermorphic mutation of phospholipase C, γ2 acquired in ibrutinib-resistant CLL confers BTK independency upon B-cell receptor activation

Ta-Ming Liu, Jennifer A. Woyach, Yiming Zhong et al. · Blood · 2015 · 174 citations · Full text

, , +17

IPI-145 antagonizes intrinsic and extrinsic survival signals in chronic lymphocytic leukemia cells

Shuai Dong, Daphne Guinn, Jason A. Dubovsky et al. · Blood · 2014 · 99 citations · Full text

, , +16

Selective targeting of NAMPT by KPT-9274 in acute myeloid leukemia

Shaneice Mitchell, Karilyn Larkin, Nicole R. Grieselhuber et al. · Blood Advances · 2019 · 64 citations · Full text

, , +17

Activation of the MAPK pathway mediates resistance to PI3K inhibitors in chronic lymphocytic leukemia

Ishwarya Murali, Siddha Kasar, Aishath Naeem et al. · Blood · 2021 · 62 citations · Full text

, , +16

Targeting Interleukin-2-inducible T-cell Kinase (ITK) and Resting Lymphocyte Kinase (RLK) Using a Novel Covalent Inhibitor PRN694

Yiming Zhong, Shuai Dong, Ethan Strattan et al. · Journal of Biological Chemistry · 2015 · 53 citations · Full text

, , +4

1–5 of 15